Latest Articles
Study: Cannabis Provides Sustained Relief for Patients With Treatment-Resistant Depression - NORML
Study: Cannabis Provides Sustained Relief for Patients With Treatment-Resistant Depression NORML
Published: Jan. 15, 2026, 6:09 p.m.
Why It’s Important to Normalize Conversations About Symptoms of Endometrial Cancer - Cancer Health
Why It’s Important to Normalize Conversations About Symptoms of Endometrial Cancer Cancer Health
Published: Jan. 15, 2026, 1:34 p.m.
Biopharma, Space Factory takes research into orbit - Il Sole 24 ORE
Biopharma, Space Factory takes research into orbit Il Sole 24 ORE
Published: Jan. 15, 2026, 5:03 a.m.
Pharmacies Use Technology to Monitor High-Risk Patients During Care Transitions - geneonline.com
Pharmacies Use Technology to Monitor High-Risk Patients During Care Transitions geneonline.com
Published: Jan. 14, 2026, 11:38 a.m.
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma - springermedicine.com
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma springermedicine.com
Published: Jan. 14, 2026, 6:02 a.m.
Scientists warn spraying perfume on neck may disrupt hormones and thyroid function - The Eastleigh Voice
Scientists warn spraying perfume on neck may disrupt hormones and thyroid function The Eastleigh Voice
Published: Jan. 14, 2026, 5:07 a.m.
ASCO 2025: key highlights in endometrial cancer - springermedicine.com
ASCO 2025: key highlights in endometrial cancer springermedicine.com
Published: Jan. 13, 2026, 5:23 a.m.
Integrating IVF and Surgical Management in Endometriosis-Associated Infertility: A Review - springermedicine.com
Integrating IVF and Surgical Management in Endometriosis-Associated Infertility: A Review springermedicine.com
Published: Jan. 13, 2026, 5:03 a.m.
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer The ASCO Post
Published: Jan. 12, 2026, 6:10 p.m.
Single hormone shot kept levels low for weeks with no short-term bone loss - Stock Titan
Single hormone shot kept levels low for weeks with no short-term bone loss Stock Titan
Published: Jan. 12, 2026, 12:30 p.m.
Link copied to clipboard!